Detalhe da pesquisa
1.
Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB) in Dutch sub-cohort of the randomized TEAM trial.
Breast Cancer Res
; 25(1): 40, 2023 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060036
2.
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
Breast Cancer Res Treat
; 180(3): 675-685, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124136
3.
Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-BRCA1/2 breast cancer families.
J Med Genet
; 56(9): 581-589, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31186341
4.
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
Int J Cancer
; 145(5): 1325-1333, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30748011
5.
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy-induced ovarian function failure.
Int J Cancer
; 145(1): 274-283, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30588619
6.
Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast Cancer.
Oncologist
; 24(7): e467-e474, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30606886
7.
Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 177(3): 723-733, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31302855
8.
Etiology of hormone receptor positive breast cancer differs by levels of histologic grade and proliferation.
Int J Cancer
; 143(4): 746-757, 2018 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29492969
9.
Cardiovascular disease incidence after internal mammary chain irradiation and anthracycline-based chemotherapy for breast cancer.
Br J Cancer
; 119(4): 408-418, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30065254
10.
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancer.
Breast Cancer Res Treat
; 168(2): 413-420, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29230665
11.
Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 18(9): 1211-1220, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732650
12.
Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial.
Lancet Oncol
; 18(11): 1502-1511, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29031778
13.
Molecular determination of the clonal relationships between multiple tumors in BRCA1/2-associated breast and/or ovarian cancer patients is clinically relevant.
Mod Pathol
; 30(1): 15-25, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612322
14.
Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups.
Breast Cancer Res
; 18(1): 104, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27756439
15.
Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
Br J Cancer
; 115(10): 1174-1178, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27755534
16.
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Breast Cancer Res Treat
; 156(3): 557-566, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060914
17.
An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat
; 157(2): 319-327, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27117159
18.
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patients.
BMC Cancer
; 16: 123, 2016 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892682
19.
Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
Int J Cancer
; 136(3): 668-77, 2015 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24947112
20.
Adjuvant radiotherapy for primary breast cancer in BRCA1 and BRCA2 mutation carriers and risk of contralateral breast cancer with special attention to patients irradiated at younger age.
Breast Cancer Res Treat
; 154(1): 171-80, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26467044